US FDA approves Takeda, Protagonist’s drug for rare blood cancer
US FDA approves Takeda, Protagonist's drug for rare blood cancer Reuters
2026
FDA approves first RAS-targeting drug for pancreatic cancer
FDA approves first RAS-targeting drug for pancreatic cancer Drug Discovery News
FDA Approves Rusfertide for Polycythemia Vera
FDA Approves Rusfertide for Polycythemia Vera OncLive
Behind the FDA Approval: Daraxonrasib Delivers in Pancreatic Cancer
Behind the FDA Approval: Daraxonrasib Delivers in Pancreatic Cancer Targeted Oncology
FDA approves new COVID vaccines
FDA approves new COVID vaccines CIDRAP